找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Chemotherapy: an Introduction; T. J. Priestman Book 1989Latest edition Springer-Verlag Berlin Heidelberg 1989 Drogen.antibiotics.br

[复制链接]
楼主: 瘦削
发表于 2025-3-25 06:09:53 | 显示全部楼层
发表于 2025-3-25 10:15:44 | 显示全部楼层
Resistance to Cytotoxic Drugs will reappear and the patient relapse despite continuing chemotherapy. This progression of disease during treatment indicates that the tumour has developed secondary resistance to the particular drugs being given. A change of agents at this time may well bring about a further remission.
发表于 2025-3-25 12:13:14 | 显示全部楼层
发表于 2025-3-25 16:02:09 | 显示全部楼层
发表于 2025-3-25 21:03:53 | 显示全部楼层
发表于 2025-3-26 02:55:55 | 显示全部楼层
发表于 2025-3-26 05:45:54 | 显示全部楼层
Book 1989Latest editiong time, there have been numerous developments in cancer chemotherapy and in order to cover these the majority of the text has been completely revised and rewritten. In addition, two new chapters have been introduced, one on the safe handling of cytotoxic drugs and the other on biological response mo
发表于 2025-3-26 10:26:11 | 显示全部楼层
发表于 2025-3-26 15:17:11 | 显示全部楼层
Enkephalin and Endorphin Receptors,At least three agents with anti-oestrogenic properties have been used in cancer treatment: tamoxifen, clomiphene citrate and nafoxidene. It is tamoxifen, however, that has come to dominate this particular therapeutic area and the remainder of this discussion will be confined to this agent.
发表于 2025-3-26 19:56:13 | 显示全部楼层
The Clinical Pharmacology of Endocrine DrugsAt least three agents with anti-oestrogenic properties have been used in cancer treatment: tamoxifen, clomiphene citrate and nafoxidene. It is tamoxifen, however, that has come to dominate this particular therapeutic area and the remainder of this discussion will be confined to this agent.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-27 05:12
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表